Clinical outcomes

Data from MRI based clinical trials and MRI-linac trials

Quantitative MRI and biomarkers

MRI biomarkers, functional imaging, treatment adaptation

AI and workflow efficiency

Contouring, adaptation, automation, decision support, MR-only workflows

Technical and physics innovations

Sequence optimization, image quality, low-field MRI

Image quality and QA

MR dosimetry, QA tool, MRI quality

Clinical trials and collaborative data initiatives

Trial proposals, Trial design, multi-center integration, data harmonization

Best practice multidisciplinary collaborations

We invite institutions to tell their story about how they interact with radiology departments (radiologist, MR physicist, radiographers) in their clinical workflow. There will be a specific session for this topic, with representation of each role/background.

Young Investigator Awards

It will be possible to submit an abstract as young investigator for nomination to the young investigator award

Structure

Abstract body (max 400 words) should be structured as:

• Purpose / Objective
• Materials and Methods
• Results
• Conclusion
• Optional References (not counted in the 400-word limit; max. 750 characters).

Title

Max 150 characters (incl. spaces). Do not use capital letters in the title except for words that are always capitalized and do not use non-standard abbreviations.

Figures and tables

• Up to 2 images may be uploaded (figures or tables as JPG/PNG).
• Ensure they are legible at approximately 1000 × 1000 pixels.
• Overcrowded or unreadable images may negatively affect scoring.

Content rules

Use standard abbreviations; define non-standard ones at first use.

• Submit via the online system by January 18, 2026.
• You may edit your abstract until the deadline.
• Only complete submissions will be reviewed.

Review and decisions

Abstracts undergo peer review within the selected topic.

Main criteria: clarity, methodology, quality of data, originality, and relevance.

The Scientific Committee decides on:

• Acceptance or rejection
• Presentation format (oral or poster)

Notification of decisions will be sent by mid-February.

Note: Acceptance does not include registration. The presenting author must register by April 30, 2026.

• Oral presentation
• Poster

Detailed instructions will follow with the acceptance letter.

By submitting, the corresponding author confirms that:

• All co-authors approve the abstract and author list.
• The abstract text is anonymous (no names or affiliations in the body).
• The work has not been published or presented in essentially the same form before, unless clearly stated.
• If accepted, the work will be presented within the official scientific programme.
• The abstract may be published in the abstract book/online programme.
• No changes to the abstract text are possible after the submission deadline.
• At least one author will register in full to attend and present the paper at the conference.